Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial

Journal of Internal Medicine

Volumn 261, Issue 1, 2007, Pages 82-90

  Spencer, C G C ^a   Felmeden, D C ^a   Blann, A D ^a   Lip, G Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Hypertension; Soluble P selectin; Von Willebrand factor

Indexed keywords

FIBRINOGEN; PADGEM PROTEIN; VON WILLEBRAND FACTOR;

ADULT; BLOOD RHEOLOGY; CARDIOVASCULAR RISK; CONFERENCE PAPER; ENDOTHELIUM; ENDOTHELIUM LESION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PLASMA VISCOSITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; THROMBOCYTE; THROMBOCYTE ACTIVATION;

AGED; BIOLOGICAL MARKERS; BLOOD VISCOSITY; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOGEN; HEALTH SURVEYS; HEMATOCRIT; HUMANS; HYPERTENSION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK ASSESSMENT; SURVIVAL RATE; VON WILLEBRAND FACTOR;

EID: 33845995793     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2006.01735.x     Document Type: Conference Paper

References (26)

1. Spencer CG, Gurney D, Blann AD, Beevers DG, Lip GY; ASCOT Steering Committee, Anglo-Scandinavian Cardiac Outcomes Trial. von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Hypertension 2002; 40: 61-6.
2. Felmeden DC, Blann AD, Spencer CG, Beevers DG, Lip GY. A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Blood Coagul Fibrinolysis 2003; 14: 425-31.
3. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356-62.
4. Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 2001; 323: 75-81.
5. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Arch Intern Med 1992; 152: 56-64.
6. Sever PS, Dahlof B, Poulter NR et al. Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. J Hypertens 2001; 19: 1139-47.
7. Dahlof B, Sever PS, Poulter NR et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendro-flumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366: 895-906.
8. Robson J, Feder G. Predicting and reducing cardiovascular risk. Heart 2001; 85: 487-8.
9. Ramachandran S, French JM, Vanderpump MPJ, Croft P, Neary RH. Using the Framingham model to predict heart disease in the United Kingdom: retrospective study. BMJ 2000; 320: 676-7.
10. Conlan MG, Folsom AR, Finch A et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. Thromb Haemostat 1993; 70: 380-5.
11. Folsom AR, Conlan MG, Davis CE, Wu KK. Relations between hemostasis variables and cardiovascular risk indicators in middle aged adults. Ann Epidemiol 1992; 2: 481-94.
12. Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GDO. Relationship between smoking and cardiovascular risk factors in the development of peripheral artery disease and coronary artery disease: the Edinburgh Artery Study. Eur Heart J 1999; 20: 344-53.
13. Yarnell JWG, Sweetnam PM, Rumley A, Lowe GDO. Lifestyle and hemostatic risk factors for ischaemic heart disease. Atheroscler Thormb Vasc Biol 2000; 20: 271-9.
14. Davi G, Romano M, Mezzetti A et al. Increased levels of soluble P-selectin in hypercholesterolaemic patients. Circulation 1998; 97: 953-7.
15. Lip GYH, Blann AD, Jones AF, Lip PL, Beevers DG. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol 1997; 80: 1566-71.
16. Folsom AR, Peacock JM, Nieto FJ et al. Plasma fibrinogen and incident hypertension in the Atherosclerosis Risk In Communities (ARIC) Study. J Hypertens 1998; 16: 1579-83.
17. Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors. Circulation 2002; 106: 1962-7.
18. Rumley A, Lowe GDO, Sweetnam PM, Yarnall JWG, Ford RP. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. Br J Haematol 1999; 105: 110-6.
19. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997; 96: 1102-8.
20. Conway DSG, Pearce LA, Chin BSP, Hart RG, Lip GYH. Prognostic value of plasma von Willebrand factor and soluble P-selection as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation 2003; 107: 3141-5.
21. Cooper JA, Miller GJ, Bauer KA et al. Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation 2000; 102: 2816-22.
22. Green D, Ruth KJ, Folsom AR, Liu K. Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb 1994; 14: 686-93.
23. Friedman GD, Tekawa I, Grimm RH, Manolio T, Shannon SG, Sidney S. The leukocyte count: correlates and relationships to coronary risk factors: the CARDIA study. Int J Epidemiol 1990; 19: 889-93.
24. Facchini F, Hollenbeck CB, Chen YN, Chen Y-DI, Reaven GM. Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women. J Intern Med 1992; 232: 267-72.
25. Danesh J, Collins R, Peto R, Lowe GDO. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 2000; 21: 515-20.
26. Wannamethee G, Shaper G. Haematocrit: relationships with blood lipids, blood pressure, and other cardiovascular risk factors. Thromb Haemost 1994; 72: 58-64.